Cargando…
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Background: The United Kingdom (UK) switched from using the 4-valent human papillomavirus (HPV) vaccine (Gardasil®) to the 9-valent vaccine (Gardasil 9®) in 2021. Objective: To estimate and compare the health and economic outcomes of 2 HPV vaccination programs in the UK targeting girls and boys aged...
Autores principales: | Owusu-Edusei, Kwame, Palmer, Cody, Ovcinnikova, Olga, Favato, Giampiero, Daniels, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170517/ https://www.ncbi.nlm.nih.gov/pubmed/35795155 http://dx.doi.org/10.36469/001c.34721 |
Ejemplares similares
-
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022) -
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022) -
Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
por: Daniels, Vincent, et al.
Publicado: (2021) -
Prevalence of COVID-19 Among Typical Ambulatory Care Patients in a District General Hospital in the United Kingdom
por: Arif, Muhammad, et al.
Publicado: (2020) -
Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)